Companies / ADR

ADHERIUM LIMITED

ASX:ADRHealth Care Equipment & ServicesSuspended from quotation
5.49B shares on issueAppendix 2A · as of 24 June 2026$0.10price · delayed$5.8Mmarket cap · indicative
NR
Dilution grade

Not rated — the company is suspended from quotation

Cash runwayno data — suspended — grade not computed
Share-count growth (24m)no data — suspended — grade not computed
Raise cadence (24m)0 cash raises
Options & rights overhangno data
In-the-money supplyno data — no recent share price on record
Pending proposed issuesopen proposed issue (Appendix 3B)

ADHERIUM LIMITED's latest reported ordinary share count is 5.49B as of June 2026; a multi-point share-count history is available (21 observations) but no first-date change percentage is provided. The company raised capital seven times in the past 24 months for total proceeds of A$23.8M, most recently a Placement and Accelerated Non-Renounceable Entitlement Offer that raised A$6.8M in March 2026. At the March 2026 quarter the company reported cash of A$-2.9M. One proposed securities issue (Appendix 3B) is pending with an expected issue date in October 2026.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
39.0%
Max option dilution
21.9%
ITM option dilution
4
Raises · last 12 months
-0.7 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 5.49B per Appendix 2A (24 June 2026).
54.7M54.9M55.1MJuly 26July 26July 26

Cash runway

-0.7 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$-2.9M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
30 June 20263G · unquotedADR : ORDINARY FULLY PAID53.7MAppendix 3G
24 June 20263G · unquotedADR : ORDINARY FULLY PAID5.37BAppendix 3G
24 June 20263H · cancellationADR : ORDINARY FULLY PAID5.37BAppendix 3H
24 June 20263G · unquotedADR : ORDINARY FULLY PAID5.37BAppendix 3G
24 June 20262A · quoted issueADR : ORDINARY FULLY PAID5.49BAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

7 cash raises in the last 24 months · 4 in the last 12 months

$6.8M
Placement and Accelerated Non-Renounceable Entitlement Offer
2 Mar 2026 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Join the waitlist

Options & convertible securities

39.0%
Total overhang · of current shares
21.9%
In the money · at current price
2.14B
Potential new shares
July 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
7 July 2026George BaranOther———3Y notice
7 July 2026Jeremy Curnock CookOther———3Y notice
7 July 2026Louis PanaccioOther———3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

26 July 2026$PAdherium - Investor Update
14 July 2026Appendix 3Y - Capital Consolidation (4 Directors)
6 July 2026Completion of Capital Consolidation
30 June 2026Notification regarding unquoted securities - ADR
29 June 2026$PAdherium enters into short-term loan funding facility
26 June 2026Change of Director's Interest Notice - Louis Panaccio
26 June 2026Change of Director's Interest Notice - George Baran
24 June 2026Notification of cessation of securities - ADR
24 June 2026Notification regarding unquoted securities - ADR
24 June 2026Notification regarding unquoted securities - ADR
24 June 2026Update to Capital Structure Records
24 June 2026Notification regarding unquoted securities - ADR
24 June 2026Cleansing Notice
24 June 2026Application for quotation of securities - ADR
23 June 2026Adherium Investor Webinar Presentation
19 June 2026Notification regarding unquoted securities - ADR
19 June 2026$PResults of Extraordinary General Meeting
17 June 2026Adherium Investor Webinar Invitation
10 June 2026Postponement of Investor Webinar
1 June 2026Initial Director's Interest Notice - Victoria Durrans

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.